Autonomous Therapeutics Inc. (ATI), a biotech company developing antiviral drugs to prevent respiratory pandemics, has relocated its headquarters from New York to Rockville, Maryland.

The three-year-old company made the move to be closer to U.S. researchers, regulators and funders in the biotech industry and found its new home in a 17,700-square-foot office space located at 1530 E. Jefferson Street. This area is part of an Opportunity Zone in Montgomery County, which gives businesses an advantage to attract future investment. This new office will house the biotech company’s manufacturing and R&D studies on its therapeutics.

ATI currently has 15 employees with plans to hire more than 50 engineers and scientists over the next three years to work out of its Rockville headquarters.

READ FULL ARTICLE HERE